Biodexa Pharmaceuticals Plc (BDRX)
0.8654
-0.03
(-3.24%)
USD |
NASDAQ |
Jun 25, 16:00
0.8654
0.00 (0.00%)
After-Hours: 20:00
Biodexa Pharmaceuticals Gross Profit (TTM): -4.597M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.597M |
| June 30, 2023 | -5.345M |
| December 31, 2022 | -5.346M |
| June 30, 2022 | -5.771M |
| December 31, 2021 | -5.575M |
| June 30, 2021 | -4.761M |
| December 31, 2020 | -7.251M |
| June 30, 2020 | -10.10M |
| Date | Value |
|---|---|
| December 31, 2019 | -9.226M |
| June 30, 2019 | -8.207M |
| December 31, 2018 | -9.856M |
| June 30, 2018 | -10.35M |
| December 31, 2017 | -9.564M |
| June 30, 2017 | -13.58M |
| December 31, 2016 | -7.818M |
| June 30, 2016 | -7.921M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-10.10M
Minimum
Jun 2020
-4.597M
Maximum
Dec 2023
-6.618M
Average
-5.673M
Median